If you’re looking to make some additions to your portfolio in January, then the three ASX shares listed below could be great options.
They have been tipped as shares that could generate strong returns for investors in the future.
Here’s why they could be five-star stocks:
This biotherapeutics giant could be a five star stock. This is due to the quality of its CSL Behring and Seqirus businesses, their leading therapies and vaccines, its growing plasma collection network, and burgeoning research and development pipeline. In respect to the latter, CSL’s pipeline contains a number of products, such as Clazakizumab, that have the potential to generate billions of dollars of sales in the future. UBS is a fan of the company and…